In a clinical trial involving patients with SLE, metformin showed a trend toward reducing disease relapse, however, the difference relative to placebo was not statistically significant ( 73 ).
← all excerpts
Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus.
1
—
—